\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ erythematous\\,\\ indurated\\,\\ waxy\\ confluent\\ plaques\\ over\\ bilateral\\ lower\\ extremities\\ with\\ hypererythematous\\ borders\\.\\ bullae\\ were\\ present\\ overlying\\ these\\ waxy\\ plaques\\ on\\ the\\ lateral\\ aspect\\ of\\ the\\ feet\\.\\ scattered\\,\\ round\\,\\ erythematous\\ papules\\ and\\ plaques\\ over\\ the\\ trunk\\ and\\ upper\\ extremities\\.\ \(0\)\
\-\ course\\:\\ prednisone\\ therapy\\ was\\ initiated\\ at\\ 80\\ mg\\ qd\\ and\\ decreased\\ by\\ 20\\ mg\\ per\\ day\\ per\\ week\\.\\ erythema\\ and\\ induration\\ of\\ the\\ plaques\\ as\\ well\\ as\\ pruritus\\ were\\ markedly\\ decreased\\.\\ the\\ patient\\ is\\ now\\ maintained\\ on\\ potent\\ topical\\ steroids\\ qd\\.\\ internal\\ medicine\\ evaluation\\ to\\ rule\\ out\\ neoplasia\\ and\\ other\\ causes\\ of\\ a\\ hypercoagulable\\ state\\ was\\ negative\\.\ \(0\)\
\-\ laboratory\\:\\ cbc\\,\\ antithrombin\\ 3\\,\\ ua\\,\\ protein\\ c\\,\\ protein\\ s\\,\\ spep\\,\\ rpr\\,\\ anticardiolipin\\,\\ lft\\'s\\,\\ chemistries\\,\\ factor\\ v\\ leiden\\,\\ all\\ wnl\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ perivascular\\ and\\ interstitial\\ eosinophils\\ and\\ lymphocytes\\ throughout\\ the\\ papillary\\ and\\ reticular\\ dermis\\.\\ focal\\ collagen\\ bundles\\ laden\\ with\\ eosinophil\\ granules\\.\\ no\\ evidence\\ of\\ panniculitis\\,\\ vasculitis\\ or\\ interface\\ dermatitis\\.\ \(0\)\
\-\ case\\ 14\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ well\\'s\\ syndrome\\ \\(eosinophilic\\ cellulitis\\)\ \(0\)\
\-\ history\\:\\ 53\\ year\\-old\\ caucasian\\ male\\ fractured\\ his\\ right\\ ankle\\ one\\ month\\ later\\ developing\\ an\\ ipsilateral\\ deep\\ venous\\ thrombosis\\ and\\ pulmonary\\ embolism\\.\\ he\\ then\\ developed\\ a\\ contralateral\\ deep\\ venous\\ thrombosis\\ after\\ being\\ placed\\ on\\ coumadin\\.\\ soon\\ thereafter\\,\\ he\\ received\\ a\\ blood\\ transfusion\\ while\\ undergoing\\ an\\ angiograrn\\ and\\ developed\\ an\\ urticarial\\ transfusion\\ reaction\\ over\\ his\\ trunk\\ coincident\\ with\\ small\\,\\ indurated\\ red\\ plaques\\ on\\ the\\ lower\\ extremities\\.\\ over\\ the\\ last\\ 3\\ months\\,\\ the\\ plaques\\ have\\ spread\\ up\\ both\\ extremities\\ and\\ the\\ patient\\ has\\ developed\\ pruritic\\ erythematous\\ papules\\ over\\ his\\ abdomen\\ and\\ neck\\.\\ within\\ one\\ week\\ of\\ his\\ initial\\ presentation\\ to\\ dermatology\\,\\ he\\ developed\\ total\\ body\\ pruritus\\,\\ erythematous\\ papules\\ and\\ plaques\\ over\\ his\\ trunk\\ and\\ upper\\ extremities\\,\\ and\\ bullae\\ on\\ the\\ lateral\\ aspect\\ of\\ his\\ feet\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.1012341517967383\ \(0\)\
\-\ erythematous\\:\\ 0\\.060186312997047756\ \(0\)\
\-\ waxy\\:\\ 0\\.05342738438767575\ \(0\)\
\-\ extremities\\:\\ 0\\.05078313059001346\ \(0\)\
\-\ papules\\:\\ 0\\.05052201714495469\ \(0\)\
\-\ trunk\\:\\ 0\\.04892301108619411\ \(0\)\
\-\ his\\:\\ 0\\.04477980050267149\ \(0\)\
\-\ pruritus\\:\\ 0\\.041633989544916275\ \(0\)\
\-\ developed\\:\\ 0\\.03987958163436017\ \(0\)\
\-\ over\\:\\ 0\\.03955713800254477\ \(0\)\
\-\ bullae\\:\\ 0\\.038894685764655317\ \(0\)\
\-\ indurated\\:\\ 0\\.03836734408593029\ \(0\)\
\-\ transfusion\\:\\ 0\\.03497573324995803\ \(0\)\
\-\ qd\\:\\ 0\\.03416645208253668\ \(0\)\
\-\ mg\\:\\ 0\\.0284144487207358\ \(0\)\
\-\ dermatology\\:\\ 0\\.027944398815609287\ \(0\)\
\-\ hypererythematous\\:\\ 0\\.026713692193837874\ \(0\)\
\-\ angiograrn\\:\\ 0\\.026713692193837874\ \(0\)\
\-\ protein\\:\\ 0\\.026573949243170813\ \(0\)\
\-\ feet\\:\\ 0\\.026502225257431403\ \(0\)\
\-\ potent\\:\\ 0\\.02461324619214107\ \(0\)\
\-\ antithrombin\\:\\ 0\\.02461324619214107\ \(0\)\
\-\ anticardiolipin\\:\\ 0\\.02461324619214107\ \(0\)\
\-\ urticarial\\:\\ 0\\.02461324619214107\ \(0\)\
\-\ laden\\:\\ 0\\.023384564046358754\ \(0\)\
\-\ eosinophil\\:\\ 0\\.023384564046358754\ \(0\)\
\-\ coincident\\:\\ 0\\.023384564046358754\ \(0\)\
\-\ per\\:\\ 0\\.022668755204440432\ \(0\)\
\-\ granules\\:\\ 0\\.022512800190444264\ \(0\)\
\-\ thrombosis\\:\\ 0\\.02223044816456391\ \(0\)\
\-\ chemistries\\:\\ 0\\.021836607610704235\ \(0\)\
\-\ he\\:\\ 0\\.02167443038211836\ \(0\)\
\-\ spep\\:\\ 0\\.02128411804466195\ \(0\)\
\-\ leiden\\:\\ 0\\.02128411804466195\ \(0\)\
\-\ deep\\:\\ 0\\.020963225147239306\ \(0\)\
\-\ induration\\:\\ 0\\.020816994772458138\ \(0\)\
\-\ panniculitis\\:\\ 0\\.020816994772458138\ \(0\)\
\-\ hypercoagulable\\:\\ 0\\.019447342882327658\ \(0\)\
\-\ pruritic\\:\\ 0\\.019447342882327658\ \(0\)\
\-\ rpr\\:\\ 0\\.019183672042965144\ \(0\)\
\-\ lft\\:\\ 0\\.019183672042965144\ \(0\)\
\-\ \\,\\:\\ 0\\.01886767123302306\ \(0\)\
\-\ venous\\:\\ 0\\.018798700717921994\ \(0\)\
\-\ eosinophils\\:\\ 0\\.018507479463225115\ \(0\)\
\-\ thereafter\\:\\ 0\\.018311908187050658\ \(0\)\
\-\ bundles\\:\\ 0\\.01812819721184934\ \(0\)\
\-\ neoplasia\\:\\ 0\\.01795498989718283\ \(0\)\
\-\ dermatitis\\:\\ 0\\.01795498989718283\ \(0\)\
\-\ topical\\:\\ 0\\.01763571560731063\ \(0\)\
\-\ perivascular\\:\\ 0\\.01763571560731063\ \(0\)\
\-\ week\\:\\ 0\\.01758797223229229\ \(0\)\
\-\ 27th\\:\\ 0\\.017487866624979014\ \(0\)\
\-\ \\:\\:\\ 0\\.017125375999858562\ \(0\)\
\-\ confluent\\:\\ 0\\.01708322604126834\ \(0\)\
\-\ reticular\\:\\ 0\\.016840672381651562\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.016726307751400514\ \(0\)\
\-\ dermis\\:\\ 0\\.016616102769064528\ \(0\)\
\-\ coumadin\\:\\ 0\\.01640703346152831\ \(0\)\
\-\ aspect\\:\\ 0\\.0162684359665658\ \(0\)\
\-\ maintained\\:\\ 0\\.016211462185353853\ \(0\)\
\-\ soon\\:\\ 0\\.016211462185353853\ \(0\)\
\-\ interface\\:\\ 0\\.016027751210152534\ \(0\)\
\-\ initiated\\:\\ 0\\.0159399101893245\ \(0\)\
\-\ fractured\\:\\ 0\\.0159399101893245\ \(0\)\
\-\ decreased\\:\\ 0\\.015398523652876119\ \(0\)\
\-\ cellulitis\\:\\ 0\\.015387420623282211\ \(0\)\
\-\ prednisone\\:\\ 0\\.015316116085675562\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.014920297351078398\ \(0\)\
\-\ collagen\\:\\ 0\\.014740226379954759\ \(0\)\
\-\ state\\:\\ 0\\.01462586174970371\ \(0\)\
\-\ histopathology\\:\\ 0\\.014462021685248327\ \(0\)\
\-\ borders\\:\\ 0\\.014409319434606301\ \(0\)\
\-\ seminar\\:\\ 0\\.014409319434606301\ \(0\)\
\-\ contralateral\\:\\ 0\\.014306587459831509\ \(0\)\
\-\ uniformed\\:\\ 0\\.01425649866603996\ \(0\)\
\-\ v\\:\\ 0\\.0142072243603679\ \(0\)\
\-\ one\\:\\ 0\\.014034735656428146\ \(0\)\
\-\ services\\:\\ 0\\.013972199407804644\ \(0\)\
\-\ 53\\:\\ 0\\.013972199407804644\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.013883066422331026\ \(0\)\
\-\ ua\\:\\ 0\\.013754097893789221\ \(0\)\
\-\ developing\\:\\ 0\\.013550645460947922\ \(0\)\
\-\ red\\:\\ 0\\.013511544234172444\ \(0\)\
\-\ wnl\\:\\ 0\\.013286974621585406\ \(0\)\
\-\ vasculitis\\:\\ 0\\.013251112628715702\ \(0\)\
\-\ factor\\:\\ 0\\.013215670083978759\ \(0\)\
\-\ papillary\\:\\ 0\\.013146004877237247\ \(0\)\
\-\ 2003\\:\\ 0\\.01301130256641654\ \(0\)\
\-\ annual\\:\\ 0\\.012978542214585581\ \(0\)\
\-\ erythema\\:\\ 0\\.012728478506440117\ \(0\)\
\-\ undergoing\\:\\ 0\\.012698623062673414\ \(0\)\
\-\ interstitial\\:\\ 0\\.01266905889617231\ \(0\)\
\-\ embolism\\:\\ 0\\.01266905889617231\ \(0\)\
\-\ spread\\:\\ 0\\.012525415748006904\ \(0\)\
\-\ upper\\:\\ 0\\.012497457608295263\ \(0\)\
\-\ caucasian\\:\\ 0\\.012361575683551522\ \(0\)\
\-\ ankle\\:\\ 0\\.01233510998667651\ \(0\)\
\-\ c\\:\\ 0\\.012308873432909496\ \(0\)\
\-\ medicine\\:\\ 0\\.012282862088390127\ \(0\)\
\-\ markedly\\:\\ 0\\.012257072119699494\ \(0\)\
\-\ 80\\:\\ 0\\.012180993570817445\ \(0\)\
\-\ steroids\\:\\ 0\\.012180993570817445\ \(0\)\
\-\ 3\\:\\ 0\\.012127124404282059\ \(0\)\
\-\ scattered\\:\\ 0\\.012058292475803091\ \(0\)\
\-\ received\\:\\ 0\\.012034337386387598\ \(0\)\
\-\ reaction\\:\\ 0\\.011760740881320625\ \(0\)\
\-\ were\\:\\ 0\\.011759311131454068\ \(0\)\
\-\ overlying\\:\\ 0\\.011717450101782817\ \(0\)\
\-\ well\\:\\ 0\\.011715642139203945\ \(0\)\
\-\ lower\\:\\ 0\\.01164764890523553\ \(0\)\
\-\ cbc\\:\\ 0\\.011570624697582979\ \(0\)\
\-\ \\'s\\:\\ 0\\.011418464353739667\ \(0\)\
\-\ 14\\:\\ 0\\.011411098232475641\ \(0\)\
\-\ lateral\\:\\ 0\\.0111919275492397\ \(0\)\
\-\ round\\:\\ 0\\.011186528619888603\ \(0\)\
\-\ total\\:\\ 0\\.011150666627018897\ \(0\)\
\-\ last\\:\\ 0\\.011062825606190861\ \(0\)\
\-\ on\\:\\ 0\\.010968045641900426\ \(0\)\
\-\ rule\\:\\ 0\\.010813619247897007\ \(0\)\
\-\ an\\:\\ 0\\.010742407857133906\ \(0\)\
\-\ placed\\:\\ 0\\.010481612573619653\ \(0\)\
\-\ causes\\:\\ 0\\.010080547569120642\ \(0\)\
\-\ course\\:\\ 0\\.009771307404411034\ \(0\)\
\-\ throughout\\:\\ 0\\.009693173716060384\ \(0\)\
\-\ laboratory\\:\\ 0\\.009542702229860806\ \(0\)\
\-\ year\\-old\\:\\ 0\\.00951140794454005\ \(0\)\
\-\ later\\:\\ 0\\.009349753457554314\ \(0\)\
\-\ 20\\:\\ 0\\.009310652230778836\ \(0\)\
\-\ then\\:\\ 0\\.009215051146733605\ \(0\)\
\-\ biopsy\\:\\ 0\\.009186949217081092\ \(0\)\
\-\ being\\:\\ 0\\.009023599929698662\ \(0\)\
\-\ presentation\\:\\ 0\\.00891939586209419\ \(0\)\
\-\ now\\:\\ 0\\.008851865423338325\ \(0\)\
\-\ internal\\:\\ 0\\.008681442034481126\ \(0\)\
\-\ initial\\:\\ 0\\.008580551949331236\ \(0\)\
\-\ out\\:\\ 0\\.008557739020783382\ \(0\)\
\-\ body\\:\\ 0\\.008409890038451771\ \(0\)\
\-\ day\\:\\ 0\\.008221090391978575\ \(0\)\
\-\ and\\:\\ 0\\.008182227533282658\ \(0\)\
\-\ while\\:\\ 0\\.008147421938946403\ \(0\)\
\-\ examination\\:\\ 0\\.00804976677416535\ \(0\)\
\-\ as\\:\\ 0\\.007833803066025017\ \(0\)\
\-\ month\\:\\ 0\\.007768528911516998\ \(0\)\
\-\ negative\\:\\ 0\\.00773369745871174\ \(0\)\
\-\ abdomen\\:\\ 0\\.007670861402714232\ \(0\)\
\-\ neck\\:\\ 0\\.007603767081874189\ \(0\)\
\-\ pulmonary\\:\\ 0\\.007565303970363829\ \(0\)\
\-\ evaluation\\:\\ 0\\.007521935744929721\ \(0\)\
\-\ s\\:\\ 0\\.007426568688226021\ \(0\)\
\-\ syndrome\\:\\ 0\\.007405777505256489\ \(0\)\
\-\ focal\\:\\ 0\\.0073954351640557634\ \(0\)\
\-\ all\\:\\ 0\\.007324010574034215\ \(0\)\
\-\ shows\\:\\ 0\\.007119314241602663\ \(0\)\
\-\ months\\:\\ 0\\.007072549377848689\ \(0\)\
\-\ blood\\:\\ 0\\.0070679123409372714\ \(0\)\
\-\ up\\:\\ 0\\.006963173185012798\ \(0\)\
\-\ therapy\\:\\ 0\\.006923153928001857\ \(0\)\
\-\ evidence\\:\\ 0\\.006789219949596599\ \(0\)\
\-\ these\\:\\ 0\\.006738923308963152\ \(0\)\
\-\ both\\:\\ 0\\.006612727244503398\ \(0\)\
\-\ bilateral\\:\\ 0\\.006284296149437709\ \(0\)\
\-\ was\\:\\ 0\\.005989560740689011\ \(0\)\
\-\ other\\:\\ 0\\.005968601662734693\ \(0\)\
\-\ small\\:\\ 0\\.005965379649639753\ \(0\)\
\-\ present\\:\\ 0\\.005848511375550548\ \(0\)\
\-\ case\\:\\ 0\\.005665164948082639\ \(0\)\
\-\ have\\:\\ 0\\.005607388116257854\ \(0\)\
\-\ after\\:\\ 0\\.005357579401846068\ \(0\)\
\-\ patient\\:\\ 0\\.005191466247978109\ \(0\)\
\-\ the\\:\\ 0\\.005027246716495484\ \(0\)\
\-\ within\\:\\ 0\\.00493979214662449\ \(0\)\
\-\ has\\:\\ 0\\.004862727183315993\ \(0\)\
\-\ male\\:\\ 0\\.004682441023901434\ \(0\)\
\-\ \\(\\:\\ 0\\.004377949856023397\ \(0\)\
\-\ \\)\\:\\ 0\\.004324470861292758\ \(0\)\
\-\ by\\:\\ 0\\.004311730009832954\ \(0\)\
\-\ a\\:\\ 0\\.003605452743805466\ \(0\)\
\-\ history\\:\\ 0\\.0035764076900214646\ \(0\)\
\-\ at\\:\\ 0\\.003508373190398888\ \(0\)\
\-\ or\\:\\ 0\\.003034917421102144\ \(0\)\
\-\ right\\:\\ 0\\.002732217300334596\ \(0\)\
\-\ no\\:\\ 0\\.0026074065172842485\ \(0\)\
\-\ to\\:\\ 0\\.002588291566321129\ \(0\)\
\-\ of\\:\\ 0\\.0021182509235997894\ \(0\)\
\-\ is\\:\\ 0\\.0017039114496506837\ \(0\)\
\-\ \\.\\:\\ 0\\.0016136152771521035\ \(0\)\
\-\ with\\:\\ 0\\.0010636743280899067\ \(0\)\
